Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.1K Buy
1,062
+50
+5% +$2.02K ﹤0.01% 687
2026
Q1
$33.5K Buy
1,012
+101
+11% +$3.28K ﹤0.01% 695
2025
Q4
$29.8K Buy
+911
New +$22.4K ﹤0.01% 607

Other funds holding AXGN

MCF Advisors's AXGN Position: Q2 2026 in Review

MCF Advisors increased its Axogen (AXGN) stake by 4.9% in Q2 2026, buying an estimated $2.02K and bringing the position to 1,062 shares worth $49.1K. The position accounts for ﹤0.01% of the portfolio, ranked #687.

MCF Advisors first reported a position in AXGN in Q4 2025 and has held it in 3 quarters since. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • MCF Advisors held 1,062 shares of Axogen worth $49.1K as of Q2 2026.
  • MCF Advisors bought 50 Axogen shares in Q2 2026, an estimated $2.02K.
  • Axogen made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #687 holding.
  • MCF Advisors first reported a position in Axogen in Q4 2025 and has held it in 3 quarters since.
  • 254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.